About Core Diagnostics
Core Diagnostics is a Healthcare company based in Gurugram (India) founded in 2012, and was acquired by Metropolis India in December 2024. Biomarker analysis and diagnostic tests are offered by the laboratory. It operates on a Subscription Services and HealthTech model. Core Diagnostics has raised $17.26 million across 2 funding rounds from investors including Metropolis India, Eight Roads Ventures and F-Prime Capital. The company has 496 employees. Its chief executive, as recorded, is Dinesh Chauhan. Its Indian entity Core Diagnostics Private Limited reported revenue of βΉ120 Cr. Core Diagnostics offers products and services including High-End Diagnostic Tests, Genetic Testing, and Subscription Health Plans. Its focus areas include Diagnostics and Clinical Diagnostics. Its competitors include Healthians, Agappe and Transasia Bio-Medicals; 2 of its 3 listed competitors have raised funding.
Company details
Core Diagnostics is established as a premier diagnostic center in India, specializing in high-end diagnostic solutions. Services are provided across a wide range of medical fields including hereditary and sporadic cancers, hematological disorders, reproductive health, cardiovascular diseases, kidney diseases, urological disorders, ophthalmologic conditions, and neurological disorders. Advanced technologies such as molecular testing, immunohistochemistry, flow cytometry, histopathology, cytopathology, and cytogenetics are utilized to ensure precise and comprehensive diagnostic outcomes. The company is trusted by numerous doctors and has impacted many patient lives through innovative diagnostic approaches.
- Headquarters Gurugram, India
- Employees 496
- Stage Acquired
- SectorsHealthcare
- Emailβ’β’β’β’β’β’β’β’
- Phoneβ’β’β’β’ β’β’β’β’
- Website corediagnostics.in
- Social LinkedIn X Facebook
- Acquired by Metropolis India (Dec 2024)
- Legal Name Core Diagnostics
- Date of Incorporation 28 Jun, 2012
- Jurisdiction Gurugram, Haryana, India
- Annual Revenue₹120 Cr
FY 2025 · +8% YoY
- Net Loss-₹18.19 Cr
FY 2025 · -15% margin
- EBITDA-₹5.23 Cr
FY 2025 · -4% margin
- Total Equity Funding$17.26M (USD)
in 2 rounds
- Latest Funding Round$12.26M (USD), Series B
Dec 2016
- InvestorsMetropolis India
& 3 more
- Employee Count496
- Acquired byMetropolis India
(Dec 2024)
Associated legal entities of Core Diagnostics
Core Diagnostics operates through Core Diagnostics Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Core Diagnostics Private Limited CIN U85100HR2012PTC046376 | Active | 28 Jun 2012 | Gurgaon, Haryana | ₹120 Cr | 496 | 4 | View details |
Products & Services of Core Diagnostics
Core Diagnostics offers a comprehensive portfolio of products and services, including High-End Diagnostic Tests, Genetic Testing, and Subscription Health Plans.
Advanced diagnostic tests for various medical conditions are provided.
Genetic tests for cardiovascular and endocrine disorders are offered.
Subscription plans for diabetes and hypertension management are available.
Funding Insights of Core Diagnostics
Core Diagnostics has successfully raised a total of $17.26M across 2 strategic funding rounds. The most recent funding activity was a Series B round of $12.26 million completed in December 2016. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $17.26M
- Total Rounds 2
- Last Round Series B β $12.26M
- First Round $5M
(Jun 2013)
- Investors Count 3
All 2 funding rounds of Core Diagnostics with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec 2016 | $12.26M | Series B | β | β | |
| Jun 2013 | $5M | Series A | β | Artiman | β |
4 investors in total: 4 institutional.
Investors in Core Diagnostics
Core Diagnostics has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include Metropolis India, Eight Roads Ventures and F-Prime Capital.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investment and global platform support for startups. | 2008 | eightroads.com | London, United Kingdom | |
Investments in life sciences, technology, healthtech, and crypto sectors from global locations. | fprimecapital.com | |||
Venture capital firm investing in technology and healthcare sectors. | 2000 | artiman.com | ||
Diagnostic centers are operated as a nationwide chain. | 1981 | metropolisindia.com | Mumbai, India |
Investor details for Core Diagnostics
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Core Diagnostics Private Limited (Core Diagnostics)
Core Diagnostics Private Limited is the primary company behind Core Diagnostics. The board of Core Diagnostics Private Limited currently have 3 directors; the longest-serving is Dinesh Chauhan, appointed in 2020. 10 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Dinesh Chauhan DIN 08773894 | Managing Director | 29 Jun 2020 | 6 yrs 4 mo | Core Diagnostics Private Limited |
| Chemmenkotil Surendran DIN 10818890 | Director | 21 Mar 2025 | 1 yr 7 mo | Core Diagnostics Private Limited |
| Avadhut Shrikant Joshi DIN 10886462 | Director | 21 Mar 2025 | 1 yr 7 mo | Core Diagnostics Private Limited |
People of Core Diagnostics
36 people are tracked at Core Diagnostics (8 in leadership, 28 in team); the tracked headcount is 496.
| Name | Role | Group |
|---|---|---|
| CEO | Leadership | |
Irfan Khan | Regional Sales Head | Leadership |
Santosh Bairiganjan | Assistant General Manager | Leadership |
Ashish Thakur | Associate Vice President Sales | Leadership |
Hemant Kansal | General Manager Speciality Sales Oncology | Leadership |
Sreenivasa Rao Karanam | Assistant General Manager | Leadership |
Animesh Paul | General Manager - Operation And Sales | Leadership |
Abhishek Tiwari | General Manager Sales | Leadership |
Ashish Singhal | Finance | Team |
Shailesh Padhiyar | Regional Sales Manager | Team |
Ajay Bhagat | Sales Manager | Team |
Pankaj Dubey | Regional Sales Manager | Team |
Sachin M | Regional Sales Manager | Team |
Aditya Singh | Buisness Development Manager | Team |
Aman Kumar | Regional Sales Manager | Team |
Puneet Narayan | Senior Regional Sales Manager | Team |
Shubhra Sharma | Assistant Manager Operations Pharma Projects | Team |
Abhishek Chauhan | Assistant Manager | Team |
Mohit Chawla | Sales Manager | Team |
Sanjay Pathak | Regional Manager Sales (oncology) | Team |
16 more people are available in the full profile.
Complete people profiles for Core Diagnostics
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Core Diagnostics
Figures of Core Diagnostics Private Limited, the primary company behind Core Diagnostics, for FY 2025. Revenue was ₹120 Cr (+8% year on year). Net loss was -₹18.19 Cr (-15% margin). EBITDA was -₹5.23 Cr (-4% margin). Revenue has grown at a compounded annual rate of +4% over three years and +22% over five years.
- ₹120 CrRevenue · FY 2025 · +8% YoY
- -₹18.19 CrNet loss · -15% margin
- -₹5.23 CrEBITDA · -4% margin
- ₹48.74 CrPaid-up capital
- 496Employees (provident fund records)
- +4%Revenue CAGR, 3 years
- +22%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Core Diagnostics Private Limited are on its company page.
Detailed financial statements for Core Diagnostics
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Core Diagnostics
4 dated milestones of Core Diagnostics across 12 years, from founding to its latest funding, stage changes and deals.
- Founded Core Diagnostics is founded.
- Funding First funding round of $5.0M.
- Funding Latest funding round, Series B, of $12.3M.
- Exit Acquired by Metropolis India.
Competitors of Core Diagnostics
Core Diagnostics has 3 listed competitors in our database, 2 of them funded. They include Healthians, Agappe and Transasia Bio-Medicals.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| healthians.com | 2014 | Gurugram, India | $80.01M | 1,730 | Online platform for at home diagnostic tests and health checkups | |
| agappe.com | 1994 | Ernakulam, India | $7.83M | In-vitro diagnostic reagents and equipment are manufactured and distributed. | ||
| transasia.co.in | 1979 | Mumbai, India | 1,295 | Diagnostic company specializing in the manufacture of in-vitro diagnostic instruments and solutions |
Detailed competitors of Core Diagnostics
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Core Diagnostics
The website of Core Diagnostics (corediagnostics.in) receives about 8.8K visits a month.
- Monthly visits8.8K
▲ 17.2% vs previous month
Websites whose visitors overlap most with Core Diagnostics. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| healthians.com | 100% | 1.3M | #61,303 | View details | |
| luciddiagnostics.com | 97% | 43.9K | #618,113 | View details | |
| neubergdiagnostics.com | 97% | 257.2K | #160,028 | View details | |
fruut.in | fruut.in | 34% | #6,625,927 | β | |
| otterfresh.in | 30% | View details | |||
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 6 similar websites and full traffic analytics for Core Diagnostics
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 6 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Top companies in Diagnostics Laboratories
3 companies that operate in the same segment as Core Diagnostics (Diagnostics Laboratories) in India, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Diagnostic testing centers for pathology and health screenings are operated. | 1996 | Mumbai, Maharashtra, India | USD 63.59 M | USD 90.17 M | 1,979 | |
Chain of pathology and radiology labs | 1949 | Gurugram, Haryana, India | USD 13.9 M | USD 294.49 M | 5,310 | |
Home-based diagnostic tests are booked via an online platform. | 2018 | Noida, Uttar Pradesh, India | USD 116.42 M | USD 41.86 M | 2,308 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Core Diagnostics
Complete news archive for Core Diagnostics
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Articles about Core Diagnostics on our blog
Frequently Asked Questions about Core Diagnostics
Core Diagnostics was founded in 2012 and raised its 1st funding round 1 year after it was founded.
Core Diagnostics is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.
Dinesh Chauhan is the CEO of Core Diagnostics, as recorded in our data.
Core Diagnostics is a funded company, having raised a total of $17.26M across 2 funding rounds to date. The company's 1st funding round was a Series A of $5M, raised on Jun 2013.
Core Diagnostics has 496 employees.
The primary company behind Core Diagnostics, Core Diagnostics Private Limited, reported revenue of βΉ120 Cr for FY 2025, up 8% year on year.
Core Diagnostics is established as a premier diagnostic center in India, specializing in high-end diagnostic solutions. Services are provided across a wide range of medical fields including hereditary and sporadic cancers, hematological disorders, reproductive health, cardiovascular diseases, kidney diseases, urological disorders, ophthalmologic conditions, and neurological disorders. Advanced technologies such as molecular testing, immunohistochemistry, flow cytometry, histopathology, cytopathology, and cytogenetics are utilized to ensure precise and comprehensive diagnostic outcomes. The company is trusted by numerous doctors and has impacted many patient lives through innovative diagnostic approaches.
Core Diagnostics's top competitors include Healthians, Transasia Bio-Medicals and Agappe.
Core Diagnostics offers High-End Diagnostic Tests, Genetic Testing, and Subscription Health Plans.
Core Diagnostics has 4 investors. Key investors include Metropolis India, Eight Roads Ventures, F-Prime Capital, and Artiman.
Core Diagnostics operates through Core Diagnostics Private Limited.
Yes. Core Diagnostics was acquired by Metropolis India in December 2024.